FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and medicine. A composition represents a powder of a substance containing a consortium of immunoglobulins IgA, IgG and IgM and target additives able to form a stable foam structure, specified in: polyethylene glycol, albumin, gelatine, pectin, casein, caseinate, casein hydrolysate, hydroxypropyl cellulose, polyglucin, dextrin, tragacanth, aerosil, glycine, L-lysine monohydrochloride, L-arginine monohydrochloride, glucose, maltose, mannitol, lactose or their mixtures; it is characterised by porous structure and fragility, has a relative disintegration shrinkage at least 10 %, equivalent pore diameter 10-110 mcm at particle size no more than 100 mcm and a resting angle less than 50° in the following proportions in 1.0 g of the composition: the consortium of immunoglobulins IgA, IgG and IgM 0.05-0.95 g; target additives - the rest. The invention provides using the composition to enable the isotropic filling of the 100% preset volume of drug containers that exceeds the effect of a similar composition by 5% and more.
EFFECT: maximum isotropic filling of the preset volume of the drug containers ensures precise dosages of the consortium of immunoglobulins.
3 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIVIRAL AND ANTIMICROBIAL ORAL COMPOSITION | 2008 |
|
RU2457856C2 |
ANTIVIRAL AND ANTIMICROBIAL COMPOSITION CONTAINING CONSORTIUM OF IMMUNOGLOBULINS | 2008 |
|
RU2457861C2 |
ANTIVIRAL AND ANTIMICROBIAL COMPOSITION | 2008 |
|
RU2457857C2 |
ANTIVIRAL AND ANTIMICROBIAL COMPOSITION | 2008 |
|
RU2457855C2 |
ORAL COMPOSITION CONTAINING NONPATHOGENIC MICROORGANISMS SHOWING ABILITY TO NORMALISE INTESTINAL MICROFLORA (VERSIONS) | 2008 |
|
RU2453320C2 |
THE ENTERIC COVER AND THE COMPOSITION FOR ITS PREPARATION | 2010 |
|
RU2442572C1 |
METHOD OF TREATING CHRONIC PAIN SYNDROME | 2014 |
|
RU2545915C1 |
BIOLOGICALLY ACTIVE ADDITION | 2000 |
|
RU2164765C1 |
COMPOSITION ELICITING ANTIVIRAL EFFECT | 2004 |
|
RU2247576C1 |
ANTIVIRAL, ANTIBACTERIAL AND ANTICANDIDOSIS AGENT | 1999 |
|
RU2144832C1 |
Authors
Dates
2012-08-10—Published
2008-08-05—Filed